Pharma · Private company
Janssen Pharmaceutica N.V., Belgium
Track this companyFree. Adds Janssen Pharmaceutica N.V., Belgium to your Dealase workspace and tells you when its record changes.
Clinical trials82 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- ApalutamidePhase 3 · Prostatic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- LHRHaPhase 3 · Prostatic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- RadiotherapyPhase 3 · Prostatic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- JNJ-55308942Phase 2 · Bipolar DisorderClinicalTrials.gov · fetched Nov 12, 2026
- JNJ-64042056Phase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SirukumabPhase 2 · Critical Confirmed Coronavirus Disease (COVID)-19ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPHPHASE3 · TERMINATED · started Jan 27, 2025ClinicalTrials.gov NCT05140525 · fetched Nov 12, 2026
- A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Jul 22, 2024ClinicalTrials.gov NCT06544616 · fetched Nov 12, 2026
- A Study of JNJ-55308942 in the Treatment of Bipolar DepressionPHASE2 · COMPLETED · started Jun 3, 2022ClinicalTrials.gov NCT05328297 · fetched Nov 12, 2026
- A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Nov 12, 2020ClinicalTrials.gov NCT04557059 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19PHASE2 · COMPLETED · started Apr 24, 2020ClinicalTrials.gov NCT04380961 · fetched Nov 12, 2026
- Study to Assess the Acceptability of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-Dose Combination (FDC) Tablets in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Pediatric Participants, Using Matching Placebo TabletsPHASE1 · COMPLETED · started Oct 10, 2019ClinicalTrials.gov NCT04006704 · fetched Nov 12, 2026
- Expansion of a Dengue-1 Live Virus Human ChallengePHASE1 · COMPLETED · started Mar 11, 2019ClinicalTrials.gov NCT03869060 · fetched Nov 12, 2026
- Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer PatientsPHASE1_PHASE2 · COMPLETED · started May 23, 2017ClinicalTrials.gov NCT02987829 · fetched Nov 12, 2026